225 related articles for article (PubMed ID: 3213801)
1. [Clinical efficacy of flucytosine on urinary candidiasis].
Yasumoto R; Asakawa M; Umeda M; Tanaka S; Tsurusaki K; Mori K; Kakinoki K; Kawashima H
Hinyokika Kiyo; 1988 Sep; 34(9):1679-82. PubMed ID: 3213801
[TBL] [Abstract][Full Text] [Related]
2. Candida urinary tract infections: treatment options.
Malani AN; Kauffman CA
Expert Rev Anti Infect Ther; 2007 Apr; 5(2):277-84. PubMed ID: 17402842
[TBL] [Abstract][Full Text] [Related]
3. [Fungal urinary infection: report no. 1].
Washida H; Tsugaya M; Hirao N; Sakagami H; Iwase Y
Hinyokika Kiyo; 1986 Oct; 32(10):1543-6. PubMed ID: 3565191
[TBL] [Abstract][Full Text] [Related]
4. [A study on urinary fungal infection].
Takeuchi H; Arai Y; Konami T; Ikeda T; Tomoyoshi T; Tatewaki K
Hinyokika Kiyo; 1983 Oct; 29(10):1273-7. PubMed ID: 6100418
[TBL] [Abstract][Full Text] [Related]
5. [In vitro antifungal activity of nitroxoline. Preliminary clinical results].
Cancet B; Amgar A
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):879-81. PubMed ID: 3309833
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of Candida urinary tract infections with reference to serum levels of anti-Candida antibody and D-arabinitol].
Tokunaga S; Ohkawa M; Hisazumi H
Hinyokika Kiyo; 1987 Dec; 33(12):1988-94. PubMed ID: 3448923
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of flucytosine in patients with urinary fungal infections].
Tokunaga S; Ohkawa M; Nakashima T; Yamaguchi K; Nishikawa T; Matsushita T; Mikawa I; Hirano S; Kawaguchi S; Miyagi T
Jpn J Antibiot; 1992 Aug; 45(8):1060-4. PubMed ID: 1433895
[TBL] [Abstract][Full Text] [Related]
8. Candida urinary tract infections--treatment.
Fisher JF; Sobel JD; Kauffman CA; Newman CA
Clin Infect Dis; 2011 May; 52 Suppl 6():S457-66. PubMed ID: 21498839
[TBL] [Abstract][Full Text] [Related]
9. [The study of urinary tract infection with a possible cause of fungi and evaluation of the efficacy of 5-FC].
Suzuki K; Tamai H
Hinyokika Kiyo; 1985 Oct; 31(10):1885-94. PubMed ID: 3911766
[TBL] [Abstract][Full Text] [Related]
10. Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital.
Muñoz P; Sánchez-Somolinos M; Alcalá L; Rodríguez-Créixems M; Peláez T; Bouza E
J Antimicrob Chemother; 2005 Feb; 55(2):188-93. PubMed ID: 15650001
[TBL] [Abstract][Full Text] [Related]
11. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of Candida species isolated from blood culture to some antifungal agents.
Citak S; Ozçelik B; Cesur S; Abbasoğlu U
Jpn J Infect Dis; 2005 Feb; 58(1):44-6. PubMed ID: 15728993
[TBL] [Abstract][Full Text] [Related]
13. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
[TBL] [Abstract][Full Text] [Related]
14. [Fluconazole in treatment of urinary candidiasis. Experience with 24 patients].
Thompson L; Pino M; Castrillón MA; Schenone D; del Canto E
Rev Med Chil; 1995 Dec; 123(12):1505-9. PubMed ID: 8733268
[TBL] [Abstract][Full Text] [Related]
15. [Candida urinary tract infection with special reference to ascending pyelonephritis].
Ohkawa M; Tokunaga S; Takashima M; Hisazumi H
Hinyokika Kiyo; 1991 Sep; 37(9):969-74. PubMed ID: 1785422
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA
Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191
[TBL] [Abstract][Full Text] [Related]
17. Treatment of fungal infections with flucytosine.
Harder EJ; Hermans PE
Arch Intern Med; 1975 Feb; 135(2):231-7. PubMed ID: 1096840
[TBL] [Abstract][Full Text] [Related]
18. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital.
Capoor MR; Nair D; Deb M; Verma PK; Srivastava L; Aggarwal P
Jpn J Infect Dis; 2005 Dec; 58(6):344-8. PubMed ID: 16377864
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
[TBL] [Abstract][Full Text] [Related]
20. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: antifungal susceptibility patterns of 261 non-albicans Candida isolates from blood.
Tortorano AM; Rigoni AL; Biraghi E; Prigitano A; Viviani MA;
J Antimicrob Chemother; 2003 Oct; 52(4):679-82. PubMed ID: 12951345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
